The Conversation (0)
Canopy Growth announced it signed a licensing agreement with Farm to Farma for the exclusive rights in Canada of their trademarked cannabis delivery method.
Canopy Growth (TSX:WEED) announced it signed a licensing agreement with Farm to Farma for the exclusive rights in Canada of their trademarked cannabis delivery method.
As quoted in the press release:
Under this licensing agreement, Canopy Growth will have the exclusive right to manufacture and distribute FTF’s Trokie lozenges through its subsidiaries in Canada, as permitted by federal regulations, and shall have a first right of offer for all other countries where federally lawful, and excluding the United States.
Developed by a Doctor of Pharmacy, Trokie lozenges have been developed to deliver a consistent and repeatable dose of cannabis to its users. Trokie features the most used polymer-based drug delivery system which allows for a zero-calorie product that avoids most common food allergies. There is no gluten, nuts, artificial flavours or colours, and the product meets vegan standards, utilizing many organic/natural ingredients.
“We are very pleased to have entered into this license agreement for the Trokie lozenges, a cannabis product that we believe has broad medical and legal adult access market opportunities,” said Mark Zekulin, President, Canopy Growth Corporation. “We are confident value-added consumer products will drive higher margins and we will continue to look for thought leaders like Farm to Farma to expand our product offerings.”
Click here to read the full press release.
Source: www.newswire.ca
